Myriad Genetics Inc. (MYGN)

Trade MYGN now with
11/6/2018 4:07:17 PM Myriad Genetics Q1 Loss Per Share $0.01, Adjusted EPS $0.43
10/22/2018 7:24:12 AM Myriad’s BRACAnalysis CDx Test Identifies Patients With Diagnosed Advanced Ovarian Cancer Who May Benefit From Lynparza
10/19/2018 7:07:35 AM Myriad Genetics Announces New Data From Two Studies Of Vectra
10/16/2018 12:20:49 PM Myriad Receives FDA Approval Of BRACAnalysis CDx As Companion Diagnostic For Pfizer’s TALZENNA
10/10/2018 7:10:21 AM Myriad Genetics Signs New Laboratory Services Agreement With Pfizer
10/9/2018 7:09:47 AM Myriad Genetics Signs Commercialization Plan With Pfizer
8/21/2018 4:08:19 PM Myriad Genetics Q4 EPS $0.18, Same As Last Year
7/31/2018 4:07:48 PM Myriad Genetics Completed Acquisition Of Counsyl
7/18/2018 7:06:22 AM Myriad Announces Coverage Decision By Kroger Prescription Plans For Vectra DA
6/28/2018 7:09:29 AM Myriad Genetics: BRACAnalysis CDx Identifies Patients Who Respond To Lynparza In SOLO-1 Study
6/21/2018 7:06:46 AM Myriad Genetics Receives Positive Medical Policy Decision For Prolaris Prostate Cancer Test